H.C. Wainwright Assumes Aldeyra Therapeutics (ALDX) at Buy

April 27, 2022 6:10 AM EDT Send to a Friend
H.C. Wainwright analyst Matt Caufield assumes coverage on Aldeyra Therapeutics (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login